Treatment of idiopathic oligozoospermia with an α-blocker: A placebo- controlled double-blind trial

International Journal of Fertility and Women's Medicine

Volumn 42, Issue 5, 1997, Pages 301-305

  Gregoriou, O ^a,b   Vitoratos, N ^a   Papadias, C ^a   Gargaropoulos, A ^a   Konidaris, S ^a   Giannopoulos, V ^a   Chryssicopoulos, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

blocker; Idiopathic oligozoospermia; Male subfertility; Terazosin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROSTANOLONE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; TERAZOSIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MALE; OLIGOSPERMIA; ORAL DRUG ADMINISTRATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPERM; SUBFERTILITY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; MALE; OLIGOSPERMIA; PRAZOSIN; PREGNANCY; PREGNANCY RATE; RADIOIMMUNOASSAY; SAFETY; SPERM COUNT; SPERM MOTILITY; TREATMENT OUTCOME;

EID: 0031424908     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bodner DR: Critical review of pharmacological therapies. Semin Reprod Endocrinol 6:379-383, 1988.
2. Steinberger E: Critical assessment of treatment results in male infertility, in Santen RH, Swerdloff RS (eds): Male Reproductive Dysfunction. Marcel Dekker, New York, pp 373-379, 1986.
3. Comhaire F: Treatment of oligozoospermia with tamoxifen. Int J Fertil 21:232-238, 1976.
4. Schellen TM, Beek JM: The influence of high doses of mesterolone on the spermiogram. Fertil Steril 23:712-714, 1978.
5. Bartsch C, Scheiber K: Tamoxifen treatment in oligozoospermia. Eur Urol 7:283-287, 1981.
6. Wang C, Chan CW, Wong KK, et al: Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline and testosterone in idiopathic oligospermia. Fertil Steril 40:358-365, 1983.
7. Yamashita Y: Fundamental and clinical studies on alpha blocker therapy for idiopathic male infertility. Jpn J Urol 82:1761-1770, 1991.
8. World Health Organization: Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, 3rd ed. The Press Syndicate of the University of Cambridge, Cambridge, p. 3, 1992.
9. Lepor H: Role of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia. Urol Clin North Am 17:651-659, 1990.
10. Lefevre-Borg F, Lechaire J, O'Connor S: In vivo uroselectivity of alfuzorin compared to prazosin and terazosin [Abstract]. Br J Pharm 106(suppl):84, 1992.
11. Yamashita Y, Nagai A, Oheda T, et al: Clinical evaluation of combined alpha blocker and beta stimulator therapy in patients with male infertility. Jpn J Fertil Steril 35:165-169, 1990.
12. Yamamoto M, Takaba H, Hashimoto J, et al: Successful treatment of oligospermic and azoospermic men with al-blocker and β-stimulator: new treatment for idiopathic male infertility. Fertil Steril 46:1162-1164, 1986.
13. Gulmez I, Tatlisen A, Karacagil M, et al: Seminal parameters of ejaculates collected successively with sixty minutes' interval in infertile men: effect of combination of prazosin and terbutaline on these parameters. Andiologia 23:167-169, 1991.
14. Yamamoto M, Hibi H, Miyake K: Comparison of the effectiveness of placebo and α-blocker for the treatment of idiopathic oligozoospermia. Fertil Steril 63:396-400, 1995.
15. Billups KL, Tillman S, Chang TSK: Ablation of the inferior mesenteric plexus in the rat: alteration of sperm storage in the epididymis and vas deferens. J Urol 143:625-629, 1990.